Keybanc analyst Kenneth Zener upgrades KB Home (NYSE:KBH) from Underweight to Sector Weight.
Why Is Cancer Focused Microcap Stock AIM ImmunoTech Trading Higher Today?
AIM ImmunoTech Inc (NYSE: AIM) announced that Roswell Park Comprehensive Cancer Center has reported the complete topline data from its Phase 1 study evaluating Ampligen (rintatolimod) as a component of a Chemokine-Modulating (CKM) regimen for the treatment of early-stage triple-